nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—TUBB2B—Vinblastine—testicular cancer	0.0933	0.115	CbGbCtD
Ixabepilone—TUBB8—Vinblastine—testicular cancer	0.0933	0.115	CbGbCtD
Ixabepilone—TUBB6—Vinblastine—testicular cancer	0.0933	0.115	CbGbCtD
Ixabepilone—TUBB2A—Vinblastine—testicular cancer	0.0933	0.115	CbGbCtD
Ixabepilone—TUBB3—Vinblastine—testicular cancer	0.0933	0.115	CbGbCtD
Ixabepilone—TUBB4A—Vinblastine—testicular cancer	0.0933	0.115	CbGbCtD
Ixabepilone—TUBB—Vinblastine—testicular cancer	0.0781	0.0965	CbGbCtD
Ixabepilone—TUBB4B—Vinblastine—testicular cancer	0.0781	0.0965	CbGbCtD
Ixabepilone—TUBB1—Vinblastine—testicular cancer	0.0781	0.0965	CbGbCtD
Ixabepilone—CYP3A4—Ifosfamide—testicular cancer	0.00628	0.00776	CbGbCtD
Ixabepilone—CYP3A4—Vinblastine—testicular cancer	0.00333	0.00412	CbGbCtD
Ixabepilone—CYP3A4—Etoposide—testicular cancer	0.003	0.00371	CbGbCtD
Ixabepilone—TUBB8—testis—testicular cancer	0.00243	0.0625	CbGeAlD
Ixabepilone—TUBB4A—embryo—testicular cancer	0.00206	0.0531	CbGeAlD
Ixabepilone—CYP3A4—Doxorubicin—testicular cancer	0.00205	0.00253	CbGbCtD
Ixabepilone—TUBB2B—seminal vesicle—testicular cancer	0.00187	0.0482	CbGeAlD
Ixabepilone—TUBB—seminal vesicle—testicular cancer	0.00177	0.0456	CbGeAlD
Ixabepilone—TUBB2A—seminal vesicle—testicular cancer	0.00176	0.0453	CbGeAlD
Ixabepilone—TUBB6—seminal vesicle—testicular cancer	0.00174	0.0447	CbGeAlD
Ixabepilone—TUBB3—testis—testicular cancer	0.00166	0.0427	CbGeAlD
Ixabepilone—TUBB1—testis—testicular cancer	0.00162	0.0417	CbGeAlD
Ixabepilone—TUBB4B—embryo—testicular cancer	0.00161	0.0414	CbGeAlD
Ixabepilone—TUBB4B—seminal vesicle—testicular cancer	0.00151	0.0389	CbGeAlD
Ixabepilone—TUBB4A—gonad—testicular cancer	0.0014	0.036	CbGeAlD
Ixabepilone—TUBB2B—gonad—testicular cancer	0.00135	0.0348	CbGeAlD
Ixabepilone—TUBB6—gonad—testicular cancer	0.00126	0.0323	CbGeAlD
Ixabepilone—TUBB4A—female gonad—testicular cancer	0.00114	0.0293	CbGeAlD
Ixabepilone—TUBB2B—female gonad—testicular cancer	0.0011	0.0283	CbGeAlD
Ixabepilone—TUBB4B—gonad—testicular cancer	0.00109	0.0281	CbGeAlD
Ixabepilone—TUBB—female gonad—testicular cancer	0.00104	0.0268	CbGeAlD
Ixabepilone—TUBB2A—female gonad—testicular cancer	0.00103	0.0266	CbGeAlD
Ixabepilone—TUBB6—female gonad—testicular cancer	0.00102	0.0263	CbGeAlD
Ixabepilone—TUBB4A—testis—testicular cancer	0.00101	0.026	CbGeAlD
Ixabepilone—TUBB2B—testis—testicular cancer	0.000975	0.0251	CbGeAlD
Ixabepilone—TUBB—testis—testicular cancer	0.000922	0.0237	CbGeAlD
Ixabepilone—TUBB2A—testis—testicular cancer	0.000918	0.0236	CbGeAlD
Ixabepilone—TUBB6—testis—testicular cancer	0.000905	0.0233	CbGeAlD
Ixabepilone—TUBB4B—female gonad—testicular cancer	0.000887	0.0228	CbGeAlD
Ixabepilone—TUBB4B—testis—testicular cancer	0.000787	0.0202	CbGeAlD
Ixabepilone—TUBB4A—lymph node—testicular cancer	0.000731	0.0188	CbGeAlD
Ixabepilone—TUBB2B—lymph node—testicular cancer	0.000707	0.0182	CbGeAlD
Ixabepilone—TUBB—lymph node—testicular cancer	0.000669	0.0172	CbGeAlD
Ixabepilone—TUBB2A—lymph node—testicular cancer	0.000665	0.0171	CbGeAlD
Ixabepilone—TUBB6—lymph node—testicular cancer	0.000656	0.0169	CbGeAlD
Ixabepilone—TUBB4B—lymph node—testicular cancer	0.00057	0.0147	CbGeAlD
Ixabepilone—Dyspnoea—Cisplatin—testicular cancer	0.000128	0.000841	CcSEcCtD
Ixabepilone—Skin disorder—Etoposide—testicular cancer	0.000128	0.00084	CcSEcCtD
Ixabepilone—Hypokalaemia—Doxorubicin—testicular cancer	0.000126	0.00083	CcSEcCtD
Ixabepilone—Angina pectoris—Epirubicin—testicular cancer	0.000126	0.00083	CcSEcCtD
Ixabepilone—Anorexia—Etoposide—testicular cancer	0.000125	0.000824	CcSEcCtD
Ixabepilone—Decreased appetite—Cisplatin—testicular cancer	0.000125	0.00082	CcSEcCtD
Ixabepilone—Diarrhoea—Dactinomycin—testicular cancer	0.000124	0.000817	CcSEcCtD
Ixabepilone—Pneumonia—Methotrexate—testicular cancer	0.000124	0.000817	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000124	0.000815	CcSEcCtD
Ixabepilone—Vomiting—Bleomycin—testicular cancer	0.000124	0.000814	CcSEcCtD
Ixabepilone—Infestation—Methotrexate—testicular cancer	0.000123	0.000812	CcSEcCtD
Ixabepilone—Infestation NOS—Methotrexate—testicular cancer	0.000123	0.000812	CcSEcCtD
Ixabepilone—Pancytopenia—Epirubicin—testicular cancer	0.000123	0.000809	CcSEcCtD
Ixabepilone—Hypotension—Etoposide—testicular cancer	0.000123	0.000808	CcSEcCtD
Ixabepilone—Rash—Bleomycin—testicular cancer	0.000123	0.000807	CcSEcCtD
Ixabepilone—Gastritis—Doxorubicin—testicular cancer	0.000123	0.000807	CcSEcCtD
Ixabepilone—Pain—Cisplatin—testicular cancer	0.000123	0.000807	CcSEcCtD
Ixabepilone—Dermatitis—Bleomycin—testicular cancer	0.000123	0.000807	CcSEcCtD
Ixabepilone—Hypersensitivity—Ifosfamide—testicular cancer	0.000123	0.000806	CcSEcCtD
Ixabepilone—Muscular weakness—Doxorubicin—testicular cancer	0.000122	0.000805	CcSEcCtD
Ixabepilone—Renal failure—Methotrexate—testicular cancer	0.000121	0.000798	CcSEcCtD
Ixabepilone—Neutropenia—Epirubicin—testicular cancer	0.000121	0.000797	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Epirubicin—testicular cancer	0.00012	0.000792	CcSEcCtD
Ixabepilone—Stomatitis—Methotrexate—testicular cancer	0.00012	0.000791	CcSEcCtD
Ixabepilone—Dysphagia—Doxorubicin—testicular cancer	0.00012	0.000788	CcSEcCtD
Ixabepilone—Asthenia—Ifosfamide—testicular cancer	0.000119	0.000785	CcSEcCtD
Ixabepilone—Paraesthesia—Etoposide—testicular cancer	0.000118	0.000776	CcSEcCtD
Ixabepilone—Pruritus—Ifosfamide—testicular cancer	0.000118	0.000774	CcSEcCtD
Ixabepilone—Weight decreased—Epirubicin—testicular cancer	0.000117	0.000771	CcSEcCtD
Ixabepilone—Dyspnoea—Etoposide—testicular cancer	0.000117	0.000771	CcSEcCtD
Ixabepilone—Angina pectoris—Doxorubicin—testicular cancer	0.000117	0.000768	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Methotrexate—testicular cancer	0.000117	0.000768	CcSEcCtD
Ixabepilone—Pneumonia—Epirubicin—testicular cancer	0.000116	0.000764	CcSEcCtD
Ixabepilone—Nausea—Bleomycin—testicular cancer	0.000116	0.000761	CcSEcCtD
Ixabepilone—Infestation NOS—Epirubicin—testicular cancer	0.000116	0.00076	CcSEcCtD
Ixabepilone—Infestation—Epirubicin—testicular cancer	0.000116	0.00076	CcSEcCtD
Ixabepilone—Vomiting—Dactinomycin—testicular cancer	0.000115	0.000759	CcSEcCtD
Ixabepilone—Rash—Dactinomycin—testicular cancer	0.000115	0.000753	CcSEcCtD
Ixabepilone—Decreased appetite—Etoposide—testicular cancer	0.000114	0.000751	CcSEcCtD
Ixabepilone—Diarrhoea—Ifosfamide—testicular cancer	0.000114	0.000749	CcSEcCtD
Ixabepilone—Pancytopenia—Doxorubicin—testicular cancer	0.000114	0.000749	CcSEcCtD
Ixabepilone—Renal failure—Epirubicin—testicular cancer	0.000114	0.000747	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Etoposide—testicular cancer	0.000113	0.000746	CcSEcCtD
Ixabepilone—Body temperature increased—Cisplatin—testicular cancer	0.000113	0.000746	CcSEcCtD
Ixabepilone—Fatigue—Etoposide—testicular cancer	0.000113	0.000745	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Epirubicin—testicular cancer	0.000113	0.000745	CcSEcCtD
Ixabepilone—Jaundice—Epirubicin—testicular cancer	0.000113	0.000741	CcSEcCtD
Ixabepilone—Stomatitis—Epirubicin—testicular cancer	0.000113	0.000741	CcSEcCtD
Ixabepilone—Constipation—Etoposide—testicular cancer	0.000112	0.000739	CcSEcCtD
Ixabepilone—Pain—Etoposide—testicular cancer	0.000112	0.000739	CcSEcCtD
Ixabepilone—Urinary tract infection—Epirubicin—testicular cancer	0.000112	0.000739	CcSEcCtD
Ixabepilone—Neutropenia—Doxorubicin—testicular cancer	0.000112	0.000737	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000111	0.000733	CcSEcCtD
Ixabepilone—Haemoglobin—Methotrexate—testicular cancer	0.000111	0.000733	CcSEcCtD
Ixabepilone—Haemorrhage—Methotrexate—testicular cancer	0.000111	0.000729	CcSEcCtD
Ixabepilone—Dizziness—Ifosfamide—testicular cancer	0.00011	0.000724	CcSEcCtD
Ixabepilone—Urinary tract disorder—Methotrexate—testicular cancer	0.000109	0.00072	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Epirubicin—testicular cancer	0.000109	0.000719	CcSEcCtD
Ixabepilone—Urethral disorder—Methotrexate—testicular cancer	0.000109	0.000714	CcSEcCtD
Ixabepilone—Weight decreased—Doxorubicin—testicular cancer	0.000108	0.000713	CcSEcCtD
Ixabepilone—Nausea—Dactinomycin—testicular cancer	0.000108	0.000709	CcSEcCtD
Ixabepilone—Pneumonia—Doxorubicin—testicular cancer	0.000108	0.000707	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Etoposide—testicular cancer	0.000107	0.000707	CcSEcCtD
Ixabepilone—Infestation NOS—Doxorubicin—testicular cancer	0.000107	0.000703	CcSEcCtD
Ixabepilone—Infestation—Doxorubicin—testicular cancer	0.000107	0.000703	CcSEcCtD
Ixabepilone—Vomiting—Ifosfamide—testicular cancer	0.000106	0.000696	CcSEcCtD
Ixabepilone—Hypersensitivity—Cisplatin—testicular cancer	0.000106	0.000695	CcSEcCtD
Ixabepilone—Renal failure—Doxorubicin—testicular cancer	0.000105	0.000691	CcSEcCtD
Ixabepilone—Rash—Ifosfamide—testicular cancer	0.000105	0.00069	CcSEcCtD
Ixabepilone—Dermatitis—Ifosfamide—testicular cancer	0.000105	0.000689	CcSEcCtD
Ixabepilone—Erythema multiforme—Methotrexate—testicular cancer	0.000105	0.000689	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000105	0.000689	CcSEcCtD
Ixabepilone—Haemoglobin—Epirubicin—testicular cancer	0.000104	0.000686	CcSEcCtD
Ixabepilone—Stomatitis—Doxorubicin—testicular cancer	0.000104	0.000685	CcSEcCtD
Ixabepilone—Jaundice—Doxorubicin—testicular cancer	0.000104	0.000685	CcSEcCtD
Ixabepilone—Abdominal pain—Etoposide—testicular cancer	0.000104	0.000683	CcSEcCtD
Ixabepilone—Body temperature increased—Etoposide—testicular cancer	0.000104	0.000683	CcSEcCtD
Ixabepilone—Urinary tract infection—Doxorubicin—testicular cancer	0.000104	0.000683	CcSEcCtD
Ixabepilone—Haemorrhage—Epirubicin—testicular cancer	0.000104	0.000682	CcSEcCtD
Ixabepilone—Eye disorder—Methotrexate—testicular cancer	0.000104	0.000681	CcSEcCtD
Ixabepilone—Hypoaesthesia—Epirubicin—testicular cancer	0.000103	0.000679	CcSEcCtD
Ixabepilone—Asthenia—Cisplatin—testicular cancer	0.000103	0.000677	CcSEcCtD
Ixabepilone—Cardiac disorder—Methotrexate—testicular cancer	0.000103	0.000676	CcSEcCtD
Ixabepilone—Urinary tract disorder—Epirubicin—testicular cancer	0.000102	0.000674	CcSEcCtD
Ixabepilone—Connective tissue disorder—Epirubicin—testicular cancer	0.000102	0.00067	CcSEcCtD
Ixabepilone—Urethral disorder—Epirubicin—testicular cancer	0.000102	0.000669	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000101	0.000665	CcSEcCtD
Ixabepilone—Angiopathy—Methotrexate—testicular cancer	0.000101	0.000661	CcSEcCtD
Ixabepilone—Immune system disorder—Methotrexate—testicular cancer	0.0001	0.000658	CcSEcCtD
Ixabepilone—Mediastinal disorder—Methotrexate—testicular cancer	9.99e-05	0.000657	CcSEcCtD
Ixabepilone—Chills—Methotrexate—testicular cancer	9.94e-05	0.000654	CcSEcCtD
Ixabepilone—Nausea—Ifosfamide—testicular cancer	9.89e-05	0.00065	CcSEcCtD
Ixabepilone—Diarrhoea—Cisplatin—testicular cancer	9.82e-05	0.000646	CcSEcCtD
Ixabepilone—Erythema multiforme—Epirubicin—testicular cancer	9.81e-05	0.000645	CcSEcCtD
Ixabepilone—Alopecia—Methotrexate—testicular cancer	9.79e-05	0.000644	CcSEcCtD
Ixabepilone—Mental disorder—Methotrexate—testicular cancer	9.71e-05	0.000639	CcSEcCtD
Ixabepilone—Eye disorder—Epirubicin—testicular cancer	9.69e-05	0.000637	CcSEcCtD
Ixabepilone—Hypersensitivity—Etoposide—testicular cancer	9.68e-05	0.000637	CcSEcCtD
Ixabepilone—Malnutrition—Methotrexate—testicular cancer	9.65e-05	0.000634	CcSEcCtD
Ixabepilone—Haemoglobin—Doxorubicin—testicular cancer	9.64e-05	0.000634	CcSEcCtD
Ixabepilone—Cardiac disorder—Epirubicin—testicular cancer	9.63e-05	0.000633	CcSEcCtD
Ixabepilone—Haemorrhage—Doxorubicin—testicular cancer	9.6e-05	0.000631	CcSEcCtD
Ixabepilone—Hypoaesthesia—Doxorubicin—testicular cancer	9.55e-05	0.000628	CcSEcCtD
Ixabepilone—Urinary tract disorder—Doxorubicin—testicular cancer	9.48e-05	0.000623	CcSEcCtD
Ixabepilone—Asthenia—Etoposide—testicular cancer	9.43e-05	0.00062	CcSEcCtD
Ixabepilone—Connective tissue disorder—Doxorubicin—testicular cancer	9.43e-05	0.00062	CcSEcCtD
Ixabepilone—Angiopathy—Epirubicin—testicular cancer	9.41e-05	0.000619	CcSEcCtD
Ixabepilone—Urethral disorder—Doxorubicin—testicular cancer	9.41e-05	0.000619	CcSEcCtD
Ixabepilone—Immune system disorder—Epirubicin—testicular cancer	9.37e-05	0.000616	CcSEcCtD
Ixabepilone—Mediastinal disorder—Epirubicin—testicular cancer	9.35e-05	0.000615	CcSEcCtD
Ixabepilone—Chills—Epirubicin—testicular cancer	9.31e-05	0.000612	CcSEcCtD
Ixabepilone—Pruritus—Etoposide—testicular cancer	9.3e-05	0.000612	CcSEcCtD
Ixabepilone—Alopecia—Epirubicin—testicular cancer	9.16e-05	0.000603	CcSEcCtD
Ixabepilone—Vomiting—Cisplatin—testicular cancer	9.12e-05	0.0006	CcSEcCtD
Ixabepilone—Mental disorder—Epirubicin—testicular cancer	9.09e-05	0.000598	CcSEcCtD
Ixabepilone—Erythema multiforme—Doxorubicin—testicular cancer	9.07e-05	0.000597	CcSEcCtD
Ixabepilone—Rash—Cisplatin—testicular cancer	9.05e-05	0.000595	CcSEcCtD
Ixabepilone—Dermatitis—Cisplatin—testicular cancer	9.04e-05	0.000594	CcSEcCtD
Ixabepilone—Malnutrition—Epirubicin—testicular cancer	9.03e-05	0.000594	CcSEcCtD
Ixabepilone—Diarrhoea—Etoposide—testicular cancer	8.99e-05	0.000591	CcSEcCtD
Ixabepilone—Eye disorder—Doxorubicin—testicular cancer	8.97e-05	0.00059	CcSEcCtD
Ixabepilone—Anaemia—Methotrexate—testicular cancer	8.92e-05	0.000586	CcSEcCtD
Ixabepilone—Cardiac disorder—Doxorubicin—testicular cancer	8.91e-05	0.000586	CcSEcCtD
Ixabepilone—Angiopathy—Doxorubicin—testicular cancer	8.71e-05	0.000573	CcSEcCtD
Ixabepilone—Dizziness—Etoposide—testicular cancer	8.69e-05	0.000572	CcSEcCtD
Ixabepilone—Muscle spasms—Epirubicin—testicular cancer	8.68e-05	0.000571	CcSEcCtD
Ixabepilone—Immune system disorder—Doxorubicin—testicular cancer	8.67e-05	0.00057	CcSEcCtD
Ixabepilone—Mediastinal disorder—Doxorubicin—testicular cancer	8.65e-05	0.000569	CcSEcCtD
Ixabepilone—Leukopenia—Methotrexate—testicular cancer	8.64e-05	0.000568	CcSEcCtD
Ixabepilone—Chills—Doxorubicin—testicular cancer	8.61e-05	0.000566	CcSEcCtD
Ixabepilone—Nausea—Cisplatin—testicular cancer	8.52e-05	0.00056	CcSEcCtD
Ixabepilone—Alopecia—Doxorubicin—testicular cancer	8.48e-05	0.000558	CcSEcCtD
Ixabepilone—Cough—Methotrexate—testicular cancer	8.42e-05	0.000554	CcSEcCtD
Ixabepilone—Mental disorder—Doxorubicin—testicular cancer	8.41e-05	0.000553	CcSEcCtD
Ixabepilone—Vomiting—Etoposide—testicular cancer	8.36e-05	0.00055	CcSEcCtD
Ixabepilone—Malnutrition—Doxorubicin—testicular cancer	8.35e-05	0.000549	CcSEcCtD
Ixabepilone—Anaemia—Epirubicin—testicular cancer	8.34e-05	0.000549	CcSEcCtD
Ixabepilone—Rash—Etoposide—testicular cancer	8.29e-05	0.000545	CcSEcCtD
Ixabepilone—Dermatitis—Etoposide—testicular cancer	8.28e-05	0.000545	CcSEcCtD
Ixabepilone—Headache—Etoposide—testicular cancer	8.23e-05	0.000542	CcSEcCtD
Ixabepilone—Arthralgia—Methotrexate—testicular cancer	8.21e-05	0.00054	CcSEcCtD
Ixabepilone—Chest pain—Methotrexate—testicular cancer	8.21e-05	0.00054	CcSEcCtD
Ixabepilone—Myalgia—Methotrexate—testicular cancer	8.21e-05	0.00054	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	8.16e-05	0.000536	CcSEcCtD
Ixabepilone—Syncope—Epirubicin—testicular cancer	8.1e-05	0.000532	CcSEcCtD
Ixabepilone—Leukopenia—Epirubicin—testicular cancer	8.08e-05	0.000531	CcSEcCtD
Ixabepilone—Muscle spasms—Doxorubicin—testicular cancer	8.03e-05	0.000528	CcSEcCtD
Ixabepilone—Loss of consciousness—Epirubicin—testicular cancer	7.94e-05	0.000522	CcSEcCtD
Ixabepilone—Cough—Epirubicin—testicular cancer	7.88e-05	0.000518	CcSEcCtD
Ixabepilone—Infection—Methotrexate—testicular cancer	7.82e-05	0.000514	CcSEcCtD
Ixabepilone—Nausea—Etoposide—testicular cancer	7.81e-05	0.000513	CcSEcCtD
Ixabepilone—Nervous system disorder—Methotrexate—testicular cancer	7.72e-05	0.000508	CcSEcCtD
Ixabepilone—Anaemia—Doxorubicin—testicular cancer	7.72e-05	0.000508	CcSEcCtD
Ixabepilone—Thrombocytopenia—Methotrexate—testicular cancer	7.71e-05	0.000507	CcSEcCtD
Ixabepilone—Arthralgia—Epirubicin—testicular cancer	7.69e-05	0.000505	CcSEcCtD
Ixabepilone—Myalgia—Epirubicin—testicular cancer	7.69e-05	0.000505	CcSEcCtD
Ixabepilone—Chest pain—Epirubicin—testicular cancer	7.69e-05	0.000505	CcSEcCtD
Ixabepilone—Skin disorder—Methotrexate—testicular cancer	7.65e-05	0.000503	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	7.63e-05	0.000502	CcSEcCtD
Ixabepilone—Anorexia—Methotrexate—testicular cancer	7.51e-05	0.000494	CcSEcCtD
Ixabepilone—Syncope—Doxorubicin—testicular cancer	7.49e-05	0.000493	CcSEcCtD
Ixabepilone—Leukopenia—Doxorubicin—testicular cancer	7.48e-05	0.000492	CcSEcCtD
Ixabepilone—Oedema—Epirubicin—testicular cancer	7.37e-05	0.000485	CcSEcCtD
Ixabepilone—Hypotension—Methotrexate—testicular cancer	7.36e-05	0.000484	CcSEcCtD
Ixabepilone—Loss of consciousness—Doxorubicin—testicular cancer	7.34e-05	0.000483	CcSEcCtD
Ixabepilone—Infection—Epirubicin—testicular cancer	7.32e-05	0.000481	CcSEcCtD
Ixabepilone—Cough—Doxorubicin—testicular cancer	7.29e-05	0.000479	CcSEcCtD
Ixabepilone—Shock—Epirubicin—testicular cancer	7.25e-05	0.000477	CcSEcCtD
Ixabepilone—Nervous system disorder—Epirubicin—testicular cancer	7.23e-05	0.000475	CcSEcCtD
Ixabepilone—Thrombocytopenia—Epirubicin—testicular cancer	7.21e-05	0.000474	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Methotrexate—testicular cancer	7.17e-05	0.000472	CcSEcCtD
Ixabepilone—Skin disorder—Epirubicin—testicular cancer	7.16e-05	0.000471	CcSEcCtD
Ixabepilone—Insomnia—Methotrexate—testicular cancer	7.12e-05	0.000468	CcSEcCtD
Ixabepilone—Chest pain—Doxorubicin—testicular cancer	7.11e-05	0.000468	CcSEcCtD
Ixabepilone—Arthralgia—Doxorubicin—testicular cancer	7.11e-05	0.000468	CcSEcCtD
Ixabepilone—Myalgia—Doxorubicin—testicular cancer	7.11e-05	0.000468	CcSEcCtD
Ixabepilone—Paraesthesia—Methotrexate—testicular cancer	7.07e-05	0.000465	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	7.06e-05	0.000464	CcSEcCtD
Ixabepilone—Anorexia—Epirubicin—testicular cancer	7.02e-05	0.000462	CcSEcCtD
Ixabepilone—Dyspnoea—Methotrexate—testicular cancer	7.02e-05	0.000462	CcSEcCtD
Ixabepilone—Hypotension—Epirubicin—testicular cancer	6.89e-05	0.000453	CcSEcCtD
Ixabepilone—Decreased appetite—Methotrexate—testicular cancer	6.84e-05	0.00045	CcSEcCtD
Ixabepilone—Oedema—Doxorubicin—testicular cancer	6.82e-05	0.000448	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Methotrexate—testicular cancer	6.8e-05	0.000447	CcSEcCtD
Ixabepilone—Fatigue—Methotrexate—testicular cancer	6.79e-05	0.000446	CcSEcCtD
Ixabepilone—Infection—Doxorubicin—testicular cancer	6.77e-05	0.000445	CcSEcCtD
Ixabepilone—Pain—Methotrexate—testicular cancer	6.73e-05	0.000443	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Epirubicin—testicular cancer	6.71e-05	0.000441	CcSEcCtD
Ixabepilone—Shock—Doxorubicin—testicular cancer	6.71e-05	0.000441	CcSEcCtD
Ixabepilone—Nervous system disorder—Doxorubicin—testicular cancer	6.69e-05	0.00044	CcSEcCtD
Ixabepilone—Thrombocytopenia—Doxorubicin—testicular cancer	6.68e-05	0.000439	CcSEcCtD
Ixabepilone—Insomnia—Epirubicin—testicular cancer	6.66e-05	0.000438	CcSEcCtD
Ixabepilone—Skin disorder—Doxorubicin—testicular cancer	6.62e-05	0.000436	CcSEcCtD
Ixabepilone—Paraesthesia—Epirubicin—testicular cancer	6.62e-05	0.000435	CcSEcCtD
Ixabepilone—Dyspnoea—Epirubicin—testicular cancer	6.57e-05	0.000432	CcSEcCtD
Ixabepilone—Anorexia—Doxorubicin—testicular cancer	6.5e-05	0.000427	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Methotrexate—testicular cancer	6.44e-05	0.000423	CcSEcCtD
Ixabepilone—Decreased appetite—Epirubicin—testicular cancer	6.41e-05	0.000421	CcSEcCtD
Ixabepilone—Hypotension—Doxorubicin—testicular cancer	6.37e-05	0.000419	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Epirubicin—testicular cancer	6.36e-05	0.000418	CcSEcCtD
Ixabepilone—Fatigue—Epirubicin—testicular cancer	6.35e-05	0.000418	CcSEcCtD
Ixabepilone—Pain—Epirubicin—testicular cancer	6.3e-05	0.000414	CcSEcCtD
Ixabepilone—Constipation—Epirubicin—testicular cancer	6.3e-05	0.000414	CcSEcCtD
Ixabepilone—Abdominal pain—Methotrexate—testicular cancer	6.22e-05	0.000409	CcSEcCtD
Ixabepilone—Body temperature increased—Methotrexate—testicular cancer	6.22e-05	0.000409	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	6.21e-05	0.000408	CcSEcCtD
Ixabepilone—Insomnia—Doxorubicin—testicular cancer	6.17e-05	0.000406	CcSEcCtD
Ixabepilone—Paraesthesia—Doxorubicin—testicular cancer	6.12e-05	0.000403	CcSEcCtD
Ixabepilone—Dyspnoea—Doxorubicin—testicular cancer	6.08e-05	0.0004	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Epirubicin—testicular cancer	6.03e-05	0.000396	CcSEcCtD
Ixabepilone—Decreased appetite—Doxorubicin—testicular cancer	5.93e-05	0.00039	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Doxorubicin—testicular cancer	5.89e-05	0.000387	CcSEcCtD
Ixabepilone—Fatigue—Doxorubicin—testicular cancer	5.88e-05	0.000387	CcSEcCtD
Ixabepilone—Pain—Doxorubicin—testicular cancer	5.83e-05	0.000383	CcSEcCtD
Ixabepilone—Constipation—Doxorubicin—testicular cancer	5.83e-05	0.000383	CcSEcCtD
Ixabepilone—Abdominal pain—Epirubicin—testicular cancer	5.82e-05	0.000383	CcSEcCtD
Ixabepilone—Body temperature increased—Epirubicin—testicular cancer	5.82e-05	0.000383	CcSEcCtD
Ixabepilone—Hypersensitivity—Methotrexate—testicular cancer	5.8e-05	0.000381	CcSEcCtD
Ixabepilone—Asthenia—Methotrexate—testicular cancer	5.65e-05	0.000372	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Doxorubicin—testicular cancer	5.57e-05	0.000367	CcSEcCtD
Ixabepilone—Pruritus—Methotrexate—testicular cancer	5.57e-05	0.000366	CcSEcCtD
Ixabepilone—Hypersensitivity—Epirubicin—testicular cancer	5.43e-05	0.000357	CcSEcCtD
Ixabepilone—Body temperature increased—Doxorubicin—testicular cancer	5.39e-05	0.000354	CcSEcCtD
Ixabepilone—Abdominal pain—Doxorubicin—testicular cancer	5.39e-05	0.000354	CcSEcCtD
Ixabepilone—Diarrhoea—Methotrexate—testicular cancer	5.39e-05	0.000354	CcSEcCtD
Ixabepilone—Asthenia—Epirubicin—testicular cancer	5.29e-05	0.000348	CcSEcCtD
Ixabepilone—Pruritus—Epirubicin—testicular cancer	5.21e-05	0.000343	CcSEcCtD
Ixabepilone—Dizziness—Methotrexate—testicular cancer	5.21e-05	0.000342	CcSEcCtD
Ixabepilone—Diarrhoea—Epirubicin—testicular cancer	5.04e-05	0.000332	CcSEcCtD
Ixabepilone—Hypersensitivity—Doxorubicin—testicular cancer	5.02e-05	0.00033	CcSEcCtD
Ixabepilone—Vomiting—Methotrexate—testicular cancer	5.01e-05	0.000329	CcSEcCtD
Ixabepilone—Rash—Methotrexate—testicular cancer	4.96e-05	0.000326	CcSEcCtD
Ixabepilone—Dermatitis—Methotrexate—testicular cancer	4.96e-05	0.000326	CcSEcCtD
Ixabepilone—Headache—Methotrexate—testicular cancer	4.93e-05	0.000324	CcSEcCtD
Ixabepilone—Asthenia—Doxorubicin—testicular cancer	4.89e-05	0.000322	CcSEcCtD
Ixabepilone—Dizziness—Epirubicin—testicular cancer	4.87e-05	0.00032	CcSEcCtD
Ixabepilone—Pruritus—Doxorubicin—testicular cancer	4.82e-05	0.000317	CcSEcCtD
Ixabepilone—Vomiting—Epirubicin—testicular cancer	4.68e-05	0.000308	CcSEcCtD
Ixabepilone—Nausea—Methotrexate—testicular cancer	4.68e-05	0.000308	CcSEcCtD
Ixabepilone—Diarrhoea—Doxorubicin—testicular cancer	4.66e-05	0.000307	CcSEcCtD
Ixabepilone—Rash—Epirubicin—testicular cancer	4.65e-05	0.000306	CcSEcCtD
Ixabepilone—Dermatitis—Epirubicin—testicular cancer	4.64e-05	0.000305	CcSEcCtD
Ixabepilone—Headache—Epirubicin—testicular cancer	4.62e-05	0.000304	CcSEcCtD
Ixabepilone—Dizziness—Doxorubicin—testicular cancer	4.51e-05	0.000296	CcSEcCtD
Ixabepilone—Nausea—Epirubicin—testicular cancer	4.38e-05	0.000288	CcSEcCtD
Ixabepilone—Vomiting—Doxorubicin—testicular cancer	4.33e-05	0.000285	CcSEcCtD
Ixabepilone—Rash—Doxorubicin—testicular cancer	4.3e-05	0.000283	CcSEcCtD
Ixabepilone—Dermatitis—Doxorubicin—testicular cancer	4.29e-05	0.000282	CcSEcCtD
Ixabepilone—Headache—Doxorubicin—testicular cancer	4.27e-05	0.000281	CcSEcCtD
Ixabepilone—Nausea—Doxorubicin—testicular cancer	4.05e-05	0.000266	CcSEcCtD
